CD133 marks a myogenically primitive subpopulation in rhabdomyosarcoma cell lines that are relatively chemoresistant but sensitive to mutant HSV.

Pressey, Joseph G; Haas, Marilyn C; Pressey, Christine S; Kelly, Virginia M; Parker, Jacqueline N; Gillespie, G Yancey; Friedman, Gregory K

Pressey, Joseph G; Haas, Marilyn C; Pressey, Christine S; Kelly, Virginia M; Parker, Jacqueline N; Gillespie, G Yancey; Friedman, Gregory K.

Affiliation

Pressey JG; Division of Hematology and Oncology, Department of Pediatrics, University of Alabama at Birmingham, Birmingham, AL 35233, USA.

Pediatr Blood Cancer ; 60(1): 45-52, 2013 Jan.

Article in En | MEDLINE | ID: mdl-22408058

Subject(s)

Antigens, CD/analysis; Drug Resistance, Neoplasm; Glycoproteins/analysis; Oncolytic Virotherapy; Peptides/analysis; Rhabdomyosarcoma/therapy; Simplexvirus/genetics; Simplexvirus/physiology; AC133 Antigen; Antigens, CD/physiology; Cell Line, Tumor; Genetic Engineering; Glycoproteins/physiology; Humans; Peptides/physiology; Receptor, Fibroblast Growth Factor, Type 3/analysis; Rhabdomyosarcoma/chemistry; Rhabdomyosarcoma/drug therapy; Rhabdomyosarcoma/pathology; Signal Transduction

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Peptides / Rhabdomyosarcoma / Glycoproteins / Antigens, CD / Simplexvirus / Drug Resistance, Neoplasm / Oncolytic Virotherapy Type of study: Diagnostic_studies Limits: Humans Language: En Journal: Pediatr Blood Cancer Journal subject: HEMATOLOGIA / NEOPLASIAS / PEDIATRIA Year: 2013 Document type: Article Affiliation country: United States Country of publication: United States

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google